ReP USP - Resultado da busca

Artigo de periodico
Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences (2023)
Rodríguez‐Cano, Borja J.; Kohek, Maja ; Ona, Genís ; Alcázar‐Córcoles, Miguel Ángel; Santos, Rafael Guimarães dos ; Hallak, Jaime Eduardo Cecilio ; Bouso, José Carlos
Source: Drug and Alcohol Review. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS, ALCALOIDES, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRÍGUEZ‐CANO, Borja J. et al. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, v. 42, n. 2, p. 401-414, 2023Tradução . . Disponível em: https://doi.org/10.1111/dar.13587. Acesso em: 18 nov. 2024.
APA
Rodríguez‐Cano, B. J., Kohek, M., Ona, G., Alcázar‐Córcoles, M. Á., Santos, R. G. dos, Hallak, J. E. C., & Bouso, J. C. (2023). Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, 42( 2), 401-414. doi:10.1111/dar.13587
NLM
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/dar.13587
Vancouver
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/dar.13587
Artigo de periodico
Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats (2023)
Cardoso, Gleice Kelli Ribeiro da Silva ; Lopes, Willian Lazarini ; Primini, Eduardo Octaviano; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Garcia-Cairasco, Norberto ; Leite-Panissi, Christie Ramos Andrade
Source: Behavioural Brain Research. Unidades: FMRP, FFCLRP
Subjects: CANNABIS, DOR CRÔNICA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Gleice Kelli Ribeiro da Silva et al. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, v. 452, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2023.114588. Acesso em: 18 nov. 2024.
APA
Cardoso, G. K. R. da S., Lopes, W. L., Primini, E. O., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., et al. (2023). Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, 452, 1-16. doi:10.1016/j.bbr.2023.114588
NLM
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Vancouver
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Artigo de periodico
Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function (2023)
Rocha, Eduardo Vieira da; Falchetti, Francisco; Pernomian, Laena; Mello, Marcela Maria Blascke de ; Parente, Juliana Montenegro ; Nogueira, Renato Corrêa; Gomes, Beatriz Quaresemin; Bertozi, Giuliana; Sanches-Lopes, Jessica M.; Tanus-Santos, José Eduardo ; Castro, Michele Mazzaron de
Source: Naunyn-Schmiedeberg's Archives of Pharmacology. Unidades: FMRP, FFCLRP
Subjects: PRESSÃO SANGUÍNEA, CARDIOMEGALIA, VASOS CORONÁRIOS, HIPERTENSÃO, FARMACOTERAPIA, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Eduardo Vieira da et al. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 396, n. 5, p. 939-949, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00210-022-02349-6. Acesso em: 18 nov. 2024.
APA
Rocha, E. V. da, Falchetti, F., Pernomian, L., Mello, M. M. B. de, Parente, J. M., Nogueira, R. C., et al. (2023). Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function. Naunyn-Schmiedeberg's Archives of Pharmacology, 396( 5), 939-949. doi:10.1007/s00210-022-02349-6
NLM
Rocha EV da, Falchetti F, Pernomian L, Mello MMB de, Parente JM, Nogueira RC, Gomes BQ, Bertozi G, Sanches-Lopes JM, Tanus-Santos JE, Castro MM de. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 5): 939-949.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00210-022-02349-6
Vancouver
Rocha EV da, Falchetti F, Pernomian L, Mello MMB de, Parente JM, Nogueira RC, Gomes BQ, Bertozi G, Sanches-Lopes JM, Tanus-Santos JE, Castro MM de. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 5): 939-949.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00210-022-02349-6
Artigo de periodico
Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy (2022)
Santos, Jeimison D.; Oliveira Neto, José Teles de ; Barros, Paula Rodrigues de; Damasceno, Luis Eduardo Alves; Lautherbach, Natalia; Assis, Ana Paula de; Silva, Carlos Alberto Aguiar da; Sorgi, Carlos Arterio ; Faccioli, Lucia Helena ; Kettelhut, Isis do Carmo ; Salgado, Hélio César ; Carneiro, Fernando Silva ; Alves-Filho, José Carlos ; Tostes, Rita de Cássia Aleixo
Source: American Journal of Physiology-Heart and Circulatory Physiology. Unidades: FMRP, FFCLRP, FCFRP
Subjects: DOENÇAS CARDIOVASCULARES, FARMACOTERAPIA, HORMÔNIOS, ESTEROIDES, TESTOSTERONA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Jeimison D. et al. Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy. American Journal of Physiology-Heart and Circulatory Physiology, v. 323, p. H322-H335, 2022Tradução . . Disponível em: https://doi.org/10.1152/ajpheart.00182.2022. Acesso em: 18 nov. 2024.
APA
Santos, J. D., Oliveira Neto, J. T. de, Barros, P. R. de, Damasceno, L. E. A., Lautherbach, N., Assis, A. P. de, et al. (2022). Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy. American Journal of Physiology-Heart and Circulatory Physiology, 323, H322-H335. doi:10.1152/ajpheart.00182.2022
NLM
Santos JD, Oliveira Neto JT de, Barros PR de, Damasceno LEA, Lautherbach N, Assis AP de, Silva CAA da, Sorgi CA, Faccioli LH, Kettelhut I do C, Salgado HC, Carneiro FS, Alves-Filho JC, Tostes R de CA. Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy [Internet]. American Journal of Physiology-Heart and Circulatory Physiology. 2022 ; 323 H322-H335.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1152/ajpheart.00182.2022
Vancouver
Santos JD, Oliveira Neto JT de, Barros PR de, Damasceno LEA, Lautherbach N, Assis AP de, Silva CAA da, Sorgi CA, Faccioli LH, Kettelhut I do C, Salgado HC, Carneiro FS, Alves-Filho JC, Tostes R de CA. Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy [Internet]. American Journal of Physiology-Heart and Circulatory Physiology. 2022 ; 323 H322-H335.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1152/ajpheart.00182.2022
Artigo de periodico
Blockade of protease-activated receptor 2 attenuates allergen-mediated acute lung inflammation and leukocyte recruitment in mice (2022)
Matos, Natália Alves de; Lima, Onésia Cristina Oliveira; Silva, Josiane Fernandes da ; Piñeros, Annie Rocio; Tavares, Juliana Carvalho; Lemos, Virgínia Soares; Alves Filho, José Carlos Farias ; Klein, Andre
Source: Journal of Biosciences. Unidade: FMRP
Subjects: MODELOS ANIMAIS DE DOENÇAS, INFLAMAÇÃO, FARMACOTERAPIA, PULMÃO, PNEUMONIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS, Natália Alves de et al. Blockade of protease-activated receptor 2 attenuates allergen-mediated acute lung inflammation and leukocyte recruitment in mice. Journal of Biosciences, v. 47, n. 1, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12038-021-00239-2. Acesso em: 18 nov. 2024.
APA
Matos, N. A. de, Lima, O. C. O., Silva, J. F. da, Piñeros, A. R., Tavares, J. C., Lemos, V. S., et al. (2022). Blockade of protease-activated receptor 2 attenuates allergen-mediated acute lung inflammation and leukocyte recruitment in mice. Journal of Biosciences, 47( 1), 1-13. doi:10.1007/s12038-021-00239-2
NLM
Matos NA de, Lima OCO, Silva JF da, Piñeros AR, Tavares JC, Lemos VS, Alves Filho JCF, Klein A. Blockade of protease-activated receptor 2 attenuates allergen-mediated acute lung inflammation and leukocyte recruitment in mice [Internet]. Journal of Biosciences. 2022 ; 47( 1): 1-13.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12038-021-00239-2
Vancouver
Matos NA de, Lima OCO, Silva JF da, Piñeros AR, Tavares JC, Lemos VS, Alves Filho JCF, Klein A. Blockade of protease-activated receptor 2 attenuates allergen-mediated acute lung inflammation and leukocyte recruitment in mice [Internet]. Journal of Biosciences. 2022 ; 47( 1): 1-13.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12038-021-00239-2
Artigo de periodico
Calcitriol reduces the inflammation, endothelial damage and oxidative stress in AKI caused by cisplatin (2022)
Oliveira, Beatriz Magalhães; Almeida, Lucas Ferreira de ; Deluque, Amanda Lima ; Souza, Cláudia Silva; Maciel, Ana Lívia Dias; Francescato, Heloísa D. C.; Costa, Roberto Silva ; Giovanini, Cleonice; Paula, Francisco Jose Albuquerque de ; Coimbra, Terezila Machado
Source: International Journal of Molecular Sciences. Unidade: FMRP
Subjects: INSUFICIÊNCIA RENAL AGUDA, FARMACOTERAPIA, ANTIOXIDANTES, INFLAMAÇÃO, RIM, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Beatriz Magalhães et al. Calcitriol reduces the inflammation, endothelial damage and oxidative stress in AKI caused by cisplatin. International Journal of Molecular Sciences, v. 23, n. 24, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms232415877. Acesso em: 18 nov. 2024.
APA
Oliveira, B. M., Almeida, L. F. de, Deluque, A. L., Souza, C. S., Maciel, A. L. D., Francescato, H. D. C., et al. (2022). Calcitriol reduces the inflammation, endothelial damage and oxidative stress in AKI caused by cisplatin. International Journal of Molecular Sciences, 23( 24), 1-14. doi:10.3390/ijms232415877
NLM
Oliveira BM, Almeida LF de, Deluque AL, Souza CS, Maciel ALD, Francescato HDC, Costa RS, Giovanini C, Paula FJA de, Coimbra TM. Calcitriol reduces the inflammation, endothelial damage and oxidative stress in AKI caused by cisplatin [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 24): 1-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ijms232415877
Vancouver
Oliveira BM, Almeida LF de, Deluque AL, Souza CS, Maciel ALD, Francescato HDC, Costa RS, Giovanini C, Paula FJA de, Coimbra TM. Calcitriol reduces the inflammation, endothelial damage and oxidative stress in AKI caused by cisplatin [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 24): 1-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ijms232415877
Artigo de periodico
Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications (2022)
Wanderley, Carlos Wagner de Souza ; Correa, Tatiana Strava; Scaranti, Mariana; Cunha, Fernando de Queiroz ; Barroso-Sousa, Romualdo
Source: Frontiers in Immunology. Unidade: FMRP
Subjects: REPARAÇÃO DE DNA, IMUNOTERAPIA, NEOPLASIAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANDERLEY, Carlos Wagner de Souza et al. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications. Frontiers in Immunology, v. 13, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.816642. Acesso em: 18 nov. 2024.
APA
Wanderley, C. W. de S., Correa, T. S., Scaranti, M., Cunha, F. de Q., & Barroso-Sousa, R. (2022). Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications. Frontiers in Immunology, 13, 1-10. doi:10.3389/fimmu.2022.816642
NLM
Wanderley CW de S, Correa TS, Scaranti M, Cunha F de Q, Barroso-Sousa R. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2022.816642
Vancouver
Wanderley CW de S, Correa TS, Scaranti M, Cunha F de Q, Barroso-Sousa R. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2022.816642
Artigo de periodico
Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma (2022)
Tavares, Marcela de Oliveira ; Milan, Thais Moré; Bighetti-Trevisan, Rayana Longo ; Leopoldino, Andréia Machado ; Almeida, Luciana Oliveira de
Source: Journal of Oral Pathology & Medicine. Unidades: FCFRP, FORP
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, FARMACOTERAPIA, LINHAGEM CELULAR, NEOPLASIAS, NEOPLASIAS DE CABEÇA E PESCOÇO, NEOPLASIAS BUCAIS, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Marcela de Oliveira et al. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, v. 51, n. 6, p. 529-537, 2022Tradução . . Disponível em: https://doi.org/10.1111/jop.13326. Acesso em: 18 nov. 2024.
APA
Tavares, M. de O., Milan, T. M., Bighetti-Trevisan, R. L., Leopoldino, A. M., & Almeida, L. O. de. (2022). Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, 51( 6), 529-537. doi:10.1111/jop.13326
NLM
Tavares M de O, Milan TM, Bighetti-Trevisan RL, Leopoldino AM, Almeida LO de. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma [Internet]. Journal of Oral Pathology & Medicine. 2022 ; 51( 6): 529-537.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/jop.13326
Vancouver
Tavares M de O, Milan TM, Bighetti-Trevisan RL, Leopoldino AM, Almeida LO de. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma [Internet]. Journal of Oral Pathology & Medicine. 2022 ; 51( 6): 529-537.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/jop.13326
Artigo de periodico
Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia (2022)
Maraschin, Jhonatan Christian; Frias, Alana Tercino ; Hernandes, Paloma Molina; Batistela, Matheus Fitipaldi; Martinez, Lucas Motta; Wegener, Sâmia Regiane Lourenço Joca ; Graeff, Frederico Guilherme; Audi, Elisabeth Aparecida; Andrade, Telma Gonçalves Carneiro Spera de; Zangrossi Junior, Hélio
Source: Behavioural Brain Research. Unidades: FCFRP, FFCLRP, FMRP
Subjects: ANALGÉSICOS, ANSIOLÍTICOS, ANTIDEPRESSIVOS, DEPRESSÃO, ANÓXIA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARASCHIN, Jhonatan Christian et al. Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia. Behavioural Brain Research, v. 418, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2021.113651. Acesso em: 18 nov. 2024.
APA
Maraschin, J. C., Frias, A. T., Hernandes, P. M., Batistela, M. F., Martinez, L. M., Wegener, S. R. L. J., et al. (2022). Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia. Behavioural Brain Research, 418. doi:10.1016/j.bbr.2021.113651
NLM
Maraschin JC, Frias AT, Hernandes PM, Batistela MF, Martinez LM, Wegener SRLJ, Graeff FG, Audi EA, Andrade TGCS de, Zangrossi Junior H. Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia [Internet]. Behavioural Brain Research. 2022 ; 418[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bbr.2021.113651
Vancouver
Maraschin JC, Frias AT, Hernandes PM, Batistela MF, Martinez LM, Wegener SRLJ, Graeff FG, Audi EA, Andrade TGCS de, Zangrossi Junior H. Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia [Internet]. Behavioural Brain Research. 2022 ; 418[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bbr.2021.113651
Artigo de periodico
Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition (2022)
Franchin, Marcelo ; Rosalen, Pedro Luiz ; Prado, Douglas da Silva ; Paraluppi, Murilo César; Silva, Rangel Leal ; Damasceno, Luis Eduardo Alves ; morelo, David Fernando Colon ; Napimoga, Marcelo Henrique; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar
Source: European Journal of Pharmacology. Unidades: CENA, FMRP
Subjects: DIFERENCIAÇÃO CELULAR, ENCEFALOMIELITE AGUDA DISSEMINADA, DOENÇAS AUTOIMUNES, INFLAMAÇÃO, FARMACOTERAPIA, INTERLEUCINAS, PRÓPOLIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCHIN, Marcelo et al. Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition. European Journal of Pharmacology, v. 929, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2022.175127. Acesso em: 18 nov. 2024.
APA
Franchin, M., Rosalen, P. L., Prado, D. da S., Paraluppi, M. C., Silva, R. L., Damasceno, L. E. A., et al. (2022). Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition. European Journal of Pharmacology, 929, 1-8. doi:10.1016/j.ejphar.2022.175127
NLM
Franchin M, Rosalen PL, Prado D da S, Paraluppi MC, Silva RL, Damasceno LEA, morelo DFC, Napimoga MH, Cunha F de Q, Alves Filho JCF, Cunha TM. Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition [Internet]. European Journal of Pharmacology. 2022 ; 929 1-8.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejphar.2022.175127
Vancouver
Franchin M, Rosalen PL, Prado D da S, Paraluppi MC, Silva RL, Damasceno LEA, morelo DFC, Napimoga MH, Cunha F de Q, Alves Filho JCF, Cunha TM. Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition [Internet]. European Journal of Pharmacology. 2022 ; 929 1-8.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejphar.2022.175127
Artigo de periodico
Riboflavin did not provide anti-inflammatory or antioxidant effects in an experimental model of sepsis (2022)
Vale, Aline Halfeld Fernandes ; Nascimento, Daniele Carvalho ; Alvarez, Annie Rocío Piñeros ; Ferreira, Raphael G. ; Santos, Jeimison Duarte ; Aragon, Davi Casale ; Cunha, Fernando de Queiroz ; Ramalho, Fernando Silva ; Alves Filho, José Carlos Farias ; Carlotti, Ana Paula de Carvalho Panzeri
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: ANTI-INFLAMATÓRIOS, ANTIOXIDANTES, INFERÊNCIA BAYESIANA, QUIMIOCINAS, CREATINA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALE, Aline Halfeld Fernandes et al. Riboflavin did not provide anti-inflammatory or antioxidant effects in an experimental model of sepsis. Brazilian Journal of Medical and Biological Research, v. 55, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2022e12107. Acesso em: 18 nov. 2024.
APA
Vale, A. H. F., Nascimento, D. C., Alvarez, A. R. P., Ferreira, R. G., Santos, J. D., Aragon, D. C., et al. (2022). Riboflavin did not provide anti-inflammatory or antioxidant effects in an experimental model of sepsis. Brazilian Journal of Medical and Biological Research, 55, 1-8. doi:10.1590/1414-431X2022e12107
NLM
Vale AHF, Nascimento DC, Alvarez ARP, Ferreira RG, Santos JD, Aragon DC, Cunha F de Q, Ramalho FS, Alves Filho JCF, Carlotti AP de CP. Riboflavin did not provide anti-inflammatory or antioxidant effects in an experimental model of sepsis [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1590/1414-431X2022e12107
Vancouver
Vale AHF, Nascimento DC, Alvarez ARP, Ferreira RG, Santos JD, Aragon DC, Cunha F de Q, Ramalho FS, Alves Filho JCF, Carlotti AP de CP. Riboflavin did not provide anti-inflammatory or antioxidant effects in an experimental model of sepsis [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1590/1414-431X2022e12107
Artigo de periodico
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia (2022)
Cortez, Isadora Lopes; Silva, Nicole R.; Rodrigues, Naielly S.; Pedrazzi, João Francisco Cordeiro; Del Bel, Elaine Aparecida ; Mechoulam, Raphael; Gomes, Felipe Villela ; Guimarães, Francisco Silveira
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FORP, FMRP
Subjects: CANABINOIDES, ESQUIZOFRENIA, FARMACOTERAPIA, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Isadora Lopes et al. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 117, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2022.110553. Acesso em: 18 nov. 2024.
APA
Cortez, I. L., Silva, N. R., Rodrigues, N. S., Pedrazzi, J. F. C., Del Bel, E. A., Mechoulam, R., et al. (2022). HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 1-9. doi:10.1016/j.pnpbp.2022.110553
NLM
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Vancouver
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Artigo de periodico
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze (2022)
Fabris, Débora; Carvalho, Milene Cristina de ; Brandão, Marcus Lira ; Prado, Wiliam Alves do; Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza ; Oliveira, Amanda R. de; Lovick, Thelma A.; Genaro, Karina
Source: Journal of Psychopharmacology. Unidades: FMRP, FFCLRP
Subjects: ANSIEDADE, ANTIDEPRESSIVOS, FARMACOTERAPIA, CANABINOIDES, DIFERENÇAS SEXUAIS ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRIS, Débora et al. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, v. 36, n. 12, p. 1371-1383, 2022Tradução . . Disponível em: https://doi.org/10.1177/02698811221125440. Acesso em: 18 nov. 2024.
APA
Fabris, D., Carvalho, M. C. de, Brandão, M. L., Prado, W. A. do, Zuardi, A. W., Crippa, J. A. de S., et al. (2022). Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, 36( 12), 1371-1383. doi:10.1177/02698811221125440
NLM
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/02698811221125440
Vancouver
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/02698811221125440
Artigo de periodico
Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD Trial (2021)
Tang, Yaling; Shah, Hetal; Bueno Júnior, Carlos Roberto ; Sun, Xiuqin; Mitri, Joanna; Sambataro, Maria; Sambado, Luisa; Gerstein, Hertzel C; Fonseca, Vivian; Doria, Alessandro; Pop-Busui, Rodica
Source: Diabetes Care. Unidade: EEFERP
Subjects: ENVELHECIMENTO, GLICOSE, PRESSÃO SANGUÍNEA, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS INSULINO-DEPENDENTE, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANG, Yaling et al. Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD Trial. Diabetes Care, v. 44, n. 1, p. 164-173, 2021Tradução . . Disponível em: https://doi.org/10.2337/dc20-1842. Acesso em: 18 nov. 2024.
APA
Tang, Y., Shah, H., Bueno Júnior, C. R., Sun, X., Mitri, J., Sambataro, M., et al. (2021). Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD Trial. Diabetes Care, 44( 1), 164-173. doi:10.2337/dc20-1842
NLM
Tang Y, Shah H, Bueno Júnior CR, Sun X, Mitri J, Sambataro M, Sambado L, Gerstein HC, Fonseca V, Doria A, Pop-Busui R. Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD Trial [Internet]. Diabetes Care. 2021 ; 44( 1): 164-173.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2337/dc20-1842
Vancouver
Tang Y, Shah H, Bueno Júnior CR, Sun X, Mitri J, Sambataro M, Sambado L, Gerstein HC, Fonseca V, Doria A, Pop-Busui R. Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD Trial [Internet]. Diabetes Care. 2021 ; 44( 1): 164-173.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2337/dc20-1842
Artigo de periodico
Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays (2021)
Tofani, Larissa Bueno; Sousa, Lucas Oliveira ; Luiz, Marcela Tavares; Abriata, Juliana Palma; Marchetti, Juliana Maldonado; Leopoldino, Andréia Machado ; Swiech, Kamilla
Source: Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: LINHAGEM CELULAR, AVALIAÇÃO DE MEDICAMENTOS, NEOPLASIAS OVARIANAS, FARMACOTERAPIA, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOFANI, Larissa Bueno et al. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays. Journal of Pharmaceutical Sciences, v. 110, n. 7, p. 2629-2636, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2021.04.003. Acesso em: 18 nov. 2024.
APA
Tofani, L. B., Sousa, L. O., Luiz, M. T., Abriata, J. P., Marchetti, J. M., Leopoldino, A. M., & Swiech, K. (2021). Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays. Journal of Pharmaceutical Sciences, 110( 7), 2629-2636. doi:10.1016/j.xphs.2021.04.003
NLM
Tofani LB, Sousa LO, Luiz MT, Abriata JP, Marchetti JM, Leopoldino AM, Swiech K. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays [Internet]. Journal of Pharmaceutical Sciences. 2021 ; 110( 7): 2629-2636.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.xphs.2021.04.003
Vancouver
Tofani LB, Sousa LO, Luiz MT, Abriata JP, Marchetti JM, Leopoldino AM, Swiech K. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays [Internet]. Journal of Pharmaceutical Sciences. 2021 ; 110( 7): 2629-2636.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.xphs.2021.04.003
Artigo de periodico
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer (2021)
Goldfarb, Shari B; Turan, Volkan; Bedoschi, Giuliano; Taylan, Enes; Abdo, Nadia; Cigler, Tessa; Bang, Heejung; Patil, Sujita; Dickler, Maura N; Oktay, Kutluk H.
Source: Breast Cancer Research and Treatment. Unidade: FMRP
Subjects: HORMÔNIO ANTIMÜLLERIANO, NEOPLASIAS MAMÁRIAS, FARMACOTERAPIA, FERTILIDADE, OVÁRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOLDFARB, Shari B et al. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research and Treatment, v. 185, n. 1, p. 165-173, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10549-020-05933-7. Acesso em: 18 nov. 2024.
APA
Goldfarb, S. B., Turan, V., Bedoschi, G., Taylan, E., Abdo, N., Cigler, T., et al. (2021). Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research and Treatment, 185( 1), 165-173. doi:10.1007/s10549-020-05933-7
NLM
Goldfarb SB, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler MN, Oktay KH. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer [Internet]. Breast Cancer Research and Treatment. 2021 ; 185( 1): 165-173.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10549-020-05933-7
Vancouver
Goldfarb SB, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler MN, Oktay KH. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer [Internet]. Breast Cancer Research and Treatment. 2021 ; 185( 1): 165-173.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10549-020-05933-7
Artigo de periodico
Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial (2021)
Guimarães, Tiago Moraes; Guimarães, Mara R. C.; Oliveira, Ícaro A. F.; Leoni, Renata Ferranti ; Santos, Antonio Carlos dos ; Dursun, Serdar M.; Crippa, José Alexandre de Souza ; Bressan, Rodrigo A.; Machado-de-Sousa, João Paulo ; Lacerda, Acioly L. T.; Hallak, Jaime Eduardo Cecilio
Source: Journal of Clinical Psychopharmacology. Unidades: FFCLRP, FMRP
Subjects: ANTIPSICÓTICOS, MÉTODO DUPLO-CEGO, FARMACOTERAPIA, ESQUIZOFRENIA, RESULTADO DE TRATAMENTO, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Tiago Moraes et al. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, v. 41, n. 3, p. 260-266, 2021Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001388. Acesso em: 18 nov. 2024.
APA
Guimarães, T. M., Guimarães, M. R. C., Oliveira, Í. A. F., Leoni, R. F., Santos, A. C. dos, Dursun, S. M., et al. (2021). Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, 41( 3), 260-266. doi:10.1097/JCP.0000000000001388
NLM
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/JCP.0000000000001388
Vancouver
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/JCP.0000000000001388
Artigo de periodico
Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure (2021)
Cavalcante, Gisele Lopes; Brognara, Fernanda ; Oliveira, Lucas Vaz de C.; Lataro, Renata M.; Durand, Marina de T.; Oliveira, Aldeidia P. de; Nóbrega, Antônio Cláudio L. da; Salgado, Hélio César ; Sabino, João Paulo J.
Source: Acta Physiologica. Unidades: FMRP, EERP
Subjects: ESTIMULAÇÃO ELÉTRICA, SISTEMA NERVOSO AUTÔNOMO, BARORREFLEXO, INSUFICIÊNCIA CARDÍACA, HIPERTENSÃO, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, Gisele Lopes et al. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure. Acta Physiologica, v. 232, n. 3, p. 1-28, 2021Tradução . . Disponível em: https://doi.org/10.1111/apha.13663. Acesso em: 18 nov. 2024.
APA
Cavalcante, G. L., Brognara, F., Oliveira, L. V. de C., Lataro, R. M., Durand, M. de T., Oliveira, A. P. de, et al. (2021). Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure. Acta Physiologica, 232( 3), 1-28. doi:10.1111/apha.13663
NLM
Cavalcante GL, Brognara F, Oliveira LV de C, Lataro RM, Durand M de T, Oliveira AP de, Nóbrega ACL da, Salgado HC, Sabino JPJ. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure [Internet]. Acta Physiologica. 2021 ; 232( 3): 1-28.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/apha.13663
Vancouver
Cavalcante GL, Brognara F, Oliveira LV de C, Lataro RM, Durand M de T, Oliveira AP de, Nóbrega ACL da, Salgado HC, Sabino JPJ. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure [Internet]. Acta Physiologica. 2021 ; 232( 3): 1-28.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/apha.13663
Artigo de periodico
The anti-cancer potential of crotoxin in estrogen receptor-positive breast cancer: its effects and mechanism of action (2021)
Almeida, Cristina Ferreira; Amaral, Cristina; Augusto, Tiago V.; Correia-da-Silva, Georgina; Andrade, Camila Marques de; Torqueti, Maria Regina ; Teixeira, Natércia
Source: Toxicon. Unidade: FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, FARMACOTERAPIA, VENENOS, CROTALIDAE, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Cristina Ferreira et al. The anti-cancer potential of crotoxin in estrogen receptor-positive breast cancer: its effects and mechanism of action. Toxicon, v. 200, p. 69-77, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.toxicon.2021.07.003. Acesso em: 18 nov. 2024.
APA
Almeida, C. F., Amaral, C., Augusto, T. V., Correia-da-Silva, G., Andrade, C. M. de, Torqueti, M. R., & Teixeira, N. (2021). The anti-cancer potential of crotoxin in estrogen receptor-positive breast cancer: its effects and mechanism of action. Toxicon, 200, 69-77. doi:10.1016/j.toxicon.2021.07.003
NLM
Almeida CF, Amaral C, Augusto TV, Correia-da-Silva G, Andrade CM de, Torqueti MR, Teixeira N. The anti-cancer potential of crotoxin in estrogen receptor-positive breast cancer: its effects and mechanism of action [Internet]. Toxicon. 2021 ; 200 69-77.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.toxicon.2021.07.003
Vancouver
Almeida CF, Amaral C, Augusto TV, Correia-da-Silva G, Andrade CM de, Torqueti MR, Teixeira N. The anti-cancer potential of crotoxin in estrogen receptor-positive breast cancer: its effects and mechanism of action [Internet]. Toxicon. 2021 ; 200 69-77.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.toxicon.2021.07.003
Artigo de periodico
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020)
Thomé, Carolina Hassibe ; Ferreira, Germano Aguiar ; Martins, Diego Antonio Pereira ; Santos, Guilherme Augusto dos; Ortiz, César Alexander; Souza, Lucas Eduardo Botelho de ; Sobral, Lays Martins; Silva, Cleide Lúcia Araújo; Scheucher, Priscila Santos ; Gil, Cristiane Damas; Leopoldino, Andréia Machado ; Silveira, Douglas Rafaele Almeida ; Silva, Juan Luiz Coelho da ; Traina, Fabiola ; Koury, Luisa C.; Melo, Raul A. M.; Bittencourt, Rosane; Pagnano, Katia; Pasquini, Ricardo; Nunes, Elenaide C.; Fagundes, Evandro M.; Gloria, Ana Beatriz F.; kerbauy, Fábio Rodrigues; Chauffaille, Maria de Lourdes; Keating, Armand; Tallman, Martin S.; Ribeiro, Raul C.; Dillon, Richard; Ganser, Arnold; Löwenberg, Bob; Valk, Peter; Lo-Coco, Francesco; Sanz, Miguel A.; Berliner, Nancy; Faça, Vitor Marcel ; Rego, Eduardo Magalhaes
Source: Scientific Reports. Unidades: FMRP, FCFRP, FM
Subjects: PROTEÍNAS, TRANSDUÇÃO DE SINAL CELULAR, QUIMIOTERAPIA, ANTINEOPLÁSICOS, MEDULA ÓSSEA, DIFERENCIAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, LEUCEMIA, FARMACOTERAPIA, ANÁLISE DE SOBREVIVÊNCIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
THOMÉ, Carolina Hassibe et al. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-66223-2. Acesso em: 18 nov. 2024.
APA
Thomé, C. H., Ferreira, G. A., Martins, D. A. P., Santos, G. A. dos, Ortiz, C. A., Souza, L. E. B. de, et al. (2020). NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, 10( 1). doi:10.1038/s41598-020-66223-2
NLM
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
Vancouver
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-020-66223-2

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration